V. Cesson

Discipline

Gestion et management (1)

Type de document

Articles (11)

Co-auteur

Date

Source

Mot-clé

Patients (8) Patients (8) Cells (7) Cancer (7) cancer (6) Cancer (6) T cells (6) Expression (5) Treatment (4) Tumors (4) Play (4) Human beings (4) Cytokines (4) Cancer--Patients (4) Blood (4) Bladder (4) Antigens (4) Ability (4) Receptors (4) Tumors (4) puits (3) protéine (3) différenciation (3) survie (3) Differentiation (3) Development (3) Blockades (3) Showing (3) Drama (3) Work (3)

Documents écrit par V. Cesson (11) | parle de V. Cesson (0)

Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer.
N. Alijaj et al. (23 févr. 2022)
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients.
S. Benmerzoug et al.
Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding.
M. Spodzieja et al. (18 janv. 2020)
Double Positive CD4+CD8+ T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization.
P. Bohner et al. (2019)
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.
M.F. Chevalier et al.
Human Bronchial Epithelial Cells Induce CD141/CD123/DC-SIGN/FLT3 Monocytes That Promote Allogeneic Th17 Differentiation.
A. Gazdhar et al. (2017)
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
M.F. Chevalier et al. (2017)
Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.
M. Spodzieja et al. (2017)
Nitric oxide sustains IL-1β expression in human dendritic cells enhancing their capacity to induce IL-17-producing T-cells.
C. Obregon et al. (2015)
MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes.
V. Cesson et al. (2011)
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
G. Bricard et al. (2009)